Skip to Content

McKesson Corp MCK

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


McKesson’s Second Consecutive Strong Quarter Exudes Confidence; Raising FVE to $198

Soo Romanoff Equity Analyst

Analyst Note

| Soo Romanoff |

Narrow-moat McKesson reported another strong quarter, with revenue growth driving profit upside as it continues to flex its scale. The quarter continues to line up with the initial distributor trend, suggesting resumption of most patient volumes with the traction of elective volumes. The strength in the quarter was broad based, with normalized growth across all segments and services offerings. The company also continues to benefit from continued traction in specialty drugs that carry higher price points in addition to the Centers for Medicare & Medicaid Services designation as the centralized supplier of COVID-19 vaccine. Despite the mix shift toward this lower-margin revenue, the better-than-expected revenue provided leverage to handily exceed consensus expectations as tracked by First Call by $0.47. Management continues to be more confident with the trending recovery of volumes and anticipated vaccine benefit, and revised guidance for the second consecutive quarter. We are raising our full-year normalized EPS to $17.20 from $16.51, largely to reflect the better-than-anticipated quarter and better outlook with the $0.45-$0.65 benefit from COVID-19 kitting and vaccines.

Read Full Analysis

Company Profile

Business Description

McKesson is the largest leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth- largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.

6555 State Highway 161
Irving, TX, 75039
T +1 972 446-4800
Sector Healthcare
Industry Medical Distribution
Most Recent Earnings Dec 31, 2020
Fiscal Year End Mar 31, 2021
Stock Type Classic Growth
Employees 80,000